HIV may cause syphilitic retinitis

Article

An increase in HIV-related syphilis has been linked with a rise in ophthalmic manifestations

An increase in HIV-related syphilis has been linked with a rise in ophthalmic manifestations, suggests a recent study from Clinical & Experimental Ophthalmology.

A team led by Dr Edward H. Hughes, Sydney Eye Hospital, Sydney, Australia, studied 13 syphilitic uveitis patients. Six were HIV-positive and 7 were HIV-negative. In case of the occurrence of viral retinitis 6 patients were treated with vitreous tap and intravitreal foscarnet.

The most frequent occurring ocular disease was peripheral retinitis panuveitis with 100% of HIV-positive patients and 14% of HIV-negative patients suffering from it. Other diseases included anterior uveitis, vitritis, multifocal choroiditis, scleritis and papillitis.

It was concluded that HIV infection appears to accommodate retinitis. The study also stresses the importance of the consideration of syphilis when diagnosing ocular diseases.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.